Predictors of cardiac sarcoidosis using commonly available cardiac studies

American Journal of Cardiology

Volumn 112, Issue 2, 2013, Pages 280-285

  Freeman, Andrew M ^a   Curran Everett, Douglas ^a   Weinberger, Howard D ^a   Fenster, Brett E ^a   Buckner, J Kern ^a   Gottschall, E Bridgette ^a   Sauer, William H ^b   Maier, Lisa A ^a,c   Hamzeh, Nabeel Y ^a,c  

^a DEPARTMENT OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOLINIUM;

ADULT; AMBULATORY MONITORING; ARTICLE; CARDIAC SARCOIDOSIS; CARDIOVASCULAR MAGNETIC RESONANCE; DIAGNOSTIC TEST ACCURACY STUDY; DIASTOLIC DYSFUNCTION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY MONITORING; EXERCISE TEST; FEMALE; HEART BUNDLE BRANCH BLOCK; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE PERFUSION; HEART RIGHT BUNDLE BRANCH BLOCK; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NUCLEAR MAGNETIC RESONANCE SCANNER; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SARCOIDOSIS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SIGNAL AVERAGED ELECTROCARDIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; CARDIAC IMAGING TECHNIQUES; CARDIOMYOPATHIES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SARCOIDOSIS;

EID: 84879843775     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.03.027     Document Type: Article

References (29)

1. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999 Am J Respir Crit Care Med 160 1999 736 755
2. A.R. Doughan, and B.R. Williams Cardiac sarcoidosis Heart 92 2006 282 288
3. K.J. Silverman, G.M. Hutchins, and B.H. Bulkley Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis Circulation 58 1978 1204 1211
4. D. Mehta, S.A. Lubitz, Z. Frankel, J.P. Wisnivesky, A.J. Einstein, M. Goldman, J. Machac, and A. Teirstein Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing Chest 133 2008 1426 1435
5. N.M. Gideon, and D.M. Mannino Sarcoidosis mortality in the United States, 1979-1991: an analysis of multiple-cause mortality data Am J Med 100 1996 423 427
6. M.A. Judson Cardiac sarcoidosis: there is no instant replay Chest 128 2005 3 6
7. O.P. Sharma, A. Maheshwari, and K. Thaker Myocardial sarcoidosis Chest 103 1993 253 258
8. H. Hiraga, M. Hiroe, and K. Iwai Guideline for Diagnosis of Cardiac Sarcoidosis: Study Report on Diffuse Pulmonary Diseases 1993 Japanese Ministry of Health and Welfare Tokyo, Japan 23-24
9. H. Eliasch, A. Juhlin-Dannfelt, I. Sjogren, and A. Terent Magnetic resonance imaging as an aid to the diagnosis and treatment evaluation of suspected myocardial sarcoidosis in a fighter pilot Aviat Space Environ Med 66 1995 1010 1013
10. M.J. Doherty, S.K. Kumar, A.A. Nicholson, and D.V. McGivern Cardiac sarcoidosis: the value of magnetic resonance imaging in diagnosis and assessment of response to treatment Respir Med 92 1998 697 699
11. O. Vignaux, R. Dhote, D. Duboc, P. Blanche, D. Dusser, S. Weber, and P. Legmann Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow up study Chest 122 2002 1895 1901
12. H. Ohira, I. Tsujino, S. Ishimaru, N. Oyama, T. Takei, E. Tsukamoto, M. Miura, S. Sakaue, N. Tamaki, and M. Nishimura Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis Eur J Nucl Med Mol Imaging 35 2008 933 941
13. N.Y. Hamzeh, F.S. Wamboldt, and H.D. Weinberger Management of cardiac sarcoidosis in the United States: a Delphi study Chest 141 2012 154 162
14. W. Okumura, T. Iwasaki, T. Toyama, T. Iso, M. Arai, N. Oriuchi, K. Endo, T. Yokoyama, T. Suzuki, and M. Kurabayashi Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis J Nucl Med 45 2004 1989 1998
15. R. Langah, K. Spicer, M. Gebregziabher, and L. Gordon Effectiveness of prolonged fasting 18f-FDG PET-CT in the detection of cardiac sarcoidosis J Nucl Cardiol 16 2009 801 810
16. P. Good Permutation, Parametric, and Bootstrap Tests of Hypotheses 3rd ed 2005 Springer New York
17. R Development Core Team R: A Language and Environment for Statistical Computing 2012 R Foundation for Statistical Computing Vienna, Austria Available at http://www.R-project.org Accessed December 27, 2012
18. C. Chapelon-Abric, D. de Zuttere, P. Duhaut, P. Veyssier, B. Wechsler, D.L. Huong, C. de Gennes, T. Papo, O. Blétry, P. Godeau, and J.C. Piette Cardiac sarcoidosis: a retrospective study of 41 cases Medicine (Baltimore) 83 2004 315 334
19. D.J. Burstow, A.J. Tajik, K.R. Bailey, R.A. DeRemee, and C.P. Taliercio Two-dimensional echocardiographic findings in systemic sarcoidosis Am J Cardiol 63 1989 478 482
20. K. Yodogawa, Y. Seino, T. Ohara, H. Takayama, Y. Kobayashi, T. Katoh, and T. Takano Non-invasive detection of latent cardiac conduction abnormalities in patients with pulmonary sarcoidosis Circ J 71 2007 540 545
21. J.L. Schuller, C.M. Lowery, M. Zipse, R.G. Aleong, P.D. Varosy, H.D. Weinberger, and W.H. Sauer Diagnostic utility of signal-averaged electrocardiography for detection of cardiac sarcoidosis Ann Noninvasive Electrocardiol 16 2011 70 76
22. F. Larsen, S.K. Pehrsson, N. Hammar, C.M. Sköld, T. Izumi, S. Nagai, M. Shigematsu, and A. Eklund ECG-abnormalities in Japanese and Swedish patients with sarcoidosis: a comparison Sarcoidosis Vasc Diffuse Lung Dis 18 2001 284 288
23. W. Schulte, D. Kirsten, M. Drent, and U. Costabel Cardiac involvement in sarcoidosis Eur Respir Soc Monogr 32 2005 130 148
24. T. Suzuki, T. Kanda, S. Kubota, S. Imai, and K. Murata Holter monitoring as a noninvasive indicator of cardiac involvement in sarcoidosis Chest 106 1994 1021 1024
25. J.P. Smedema, G. Snoep, M.P. van Kroonenburgh, R.J. van Geuns, W.R. Dassen, A.P. Gorgels, and H.J. Crijns Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis J Am Coll Cardiol 45 2005 1683 1690
26. H. Yamagishi, N. Shirai, M. Takagi, M. Yoshiyama, K. Akioka, and J. Yoshikawa Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET J Nucl Med 44 2003 1030 1036
27. S. Ishimaru, I. Tsujino, T. Takei, E. Tsukamoto, S. Sakaue, M. Kamigaki, N. Ito, H. Ohira, D. Ikeda, N. Tamaki, and M. Nishimura Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis Eur Heart J 26 2005 1538 1543
28. P. Campbell, G.C. Stewart, R.F. Padera, R.N. Mitchell, G.L. Winters, W.G. Stevenson, R.Y. Kwong, M.F. Di Carli, and L.W. Stevenson Evaluation for cardiac sarcoidosis - uncertainty despite contemporary multi-modality imaging J Card Failure 16 2010 S107
29. K.G. Ordovas, and C.B. Higgins Delayed contrast enhancement on MR images of myocardium: past, present, future Radiology 261 2011 358 374